Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bristol-Myers-Squibb
Company Monitoring Page for Bristol-Myers-Squibb
latest headlines for company on cafepharma
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
Tags:
AbbVie
,
Amgen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sceinces
,
JNJ
,
Merck
,
Pfizer
,
Regeneron
,
patents
,
activists
Bristol Myers boosts cell therapy production with Novartis plant
BioPharma Dive
Wed, 04/26/23 - 05:40 pm
Tags:
Bristol Myers Squibb
,
cell therapy
,
Novartis
,
drug manufacturing
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
Tags:
M&A
,
R&D
,
AbbVie
,
AstraZeneca
,
Bristol Myers Squibb
,
Eli Lilly
,
GSK
,
JNJ
,
Merck
,
Novartis
,
Pfizer
,
Roche
,
Sanofi
BMS signs ADC development deal with Munich-based biotech worth more than $1B
Medical Marketing and Media
Thu, 04/20/23 - 12:00 pm
Tags:
Bristol Myers Squibb
,
Tubulius
,
cancer
,
solid tumors
,
antibody-drug conjugate
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
Tags:
CAR-T
,
Bristol Myers Squibb
,
JNJ
,
Legend Biotech
,
AACR
,
Multiple Myeloma
,
Carvykti
,
Abecma
Foundation Medicine to collaborate with Bristol Myers Squibb on companion diagnostic for solid tumors
LabPulse
Tue, 04/11/23 - 07:25 pm
Tags:
Bristol Myers Squibb
,
Foundation Medicine
,
diagnostics
,
FoundationOne
,
companion diagnostics
,
repotrectinib
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
Tags:
CVS Health
,
Signify Health
,
M&A
,
Ferring Pharmaceuticals
,
Pfizer
,
Bristol Myers Squibb
,
Eli Lilly
,
Novo Nordisk
,
Boehringer Ingelheim
,
Jardiance
,
Ozempic
,
drug pricing
,
Eliquis
,
CMS
Mon, 04/3/23 - 03:26 pm
Tags:
CVS Health
,
Signify Health
,
M&A
,
Ferring Pharmaceuticals
,
Pfizer
,
Bristol Myers Squibb
,
Eli Lilly
,
Novo Nordisk
,
Boehringer Ingelheim
,
Jardiance
,
Ozempic
,
drug pricing
,
Eliquis
,
CMS
Bristol Myers Squibb Takes Off on Latest SpaceX Flight for Protein Crystallization Research
Xtalks
Sun, 04/2/23 - 04:27 pm
Tags:
Bristol Myers Squibb
,
SpaceX
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
Tags:
EMA
,
Europe
,
CHMP
,
Wegovy
,
Novo Nordisk
,
Bimervax
,
TG Therapeutics
,
Eli Lilly
,
Bristol Myers Squibb
,
Novartis
,
AstraZeneca
Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours
Clinical Trials Arena
Fri, 03/31/23 - 10:22 am
Tags:
Bolt Biotherapeutics
,
BDC-1001
,
solid tumors
,
Roche
,
Bristol Myers Squibb
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Fierce Pharma
Thu, 03/30/23 - 10:59 am
Tags:
Pfizer
,
Bristol Myers Squibb
,
Eliquis
,
drug pricing
,
Inflation Reduction Act
,
CMS
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
Motley Fool
Tue, 03/28/23 - 10:46 pm
Tags:
clinical trials
,
Bristol Myers Squibb
,
JNJ
,
milvexian
,
stroke
BMS re-ups 'highly productive' legacy neurodegeneration partnership with Evotec for $50M upfront
Fierce Biotech
Tue, 03/28/23 - 10:44 pm
Tags:
Bristol Myers Squibb
,
Celgene
,
Evotec
,
neurodegenerative disease
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D
,
Roche
,
JNJ
,
Merck
,
Pfizer
,
Novartis
,
AstraZeneca
,
Bristol Myers Squibb
,
Eli Lilly
,
Sanofi
,
AbbVie
Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data
BioPharma Dive
Sun, 03/19/23 - 01:46 pm
Tags:
Takeda
,
Bristol Myers Squibb
,
clinical trials
,
TAK-279
,
plaque psoriasis
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Tags:
Medtronic
,
Medtech
,
inflation
,
drug pricing
,
Pfizer
,
Novartis
,
Merck
,
Bristol Myers Squibb
,
Keytruda
,
Opdivo
,
Yervoy
,
lung cancer
,
Xiidra
,
JNJ
,
executive compensation
Sat, 03/18/23 - 03:34 pm
Tags:
Medtronic
,
Medtech
,
inflation
,
drug pricing
,
Pfizer
,
Novartis
,
Merck
,
Bristol Myers Squibb
,
Keytruda
,
Opdivo
,
Yervoy
,
lung cancer
,
Xiidra
,
JNJ
,
executive compensation
Bristol Myers meets some diversity goals early, while missing others
Endpoints
Wed, 03/15/23 - 09:28 pm
Tags:
Bristol Myers Squibb
,
diversity
,
clinical trials
,
clinical trial diversity
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.